These are some of the main recommendations of the European Medical Research Councils (EMRC) White Paper, ‘Present Status and Future Strategy for Medical Research in Europe’ which was debated at a meeting on 30 January 2008 in Frankfurt (Germany) with the participation of the Heads of Medical Research Councils in Europe, Editors of Medical Journals, Presidents of Medical Learned Societies and Deans of Medical Faculties in Europe.
The audience acclaimed the White paper and made the following recommendations:
Increased funding must be by sustainable growth,
Collaboration on big programmes is essential,
Research areas should be determined by health priorities and not only science topics,
Collaboration on an improvement of peer review of grants is essential - and peer reviewers should be acknowledged and rewarded,
MD/PhD programmes are important and should be of high quality,
the best researchers - like the Nobel Laureates at The Lindau meeting - to participate in teaching,
Novel technologies and research infrastructures are important as well as incentive in terms of decent salaries to attract and retain young researchers
To make the White Paper recommendations come true European and global collaboration is needed.
The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe together with an assessment of the new challenges facing Europe’s citizens, with changing patterns of disease, environmental issues as global warming, and changing demographic factors with an ageing population. The paper was launched at a meeting between Janez Potocnik, EU Commissioner for Science and Research, and Professor Liselotte Højgaard, Chair of the European Medical Research Councils in Brussels on 6 December 2007.
The White Paper key recommendations include:
Implementation of best practice for funding and performing medical research – with distribution of funding in competition based on excellence and evaluated by peer review
Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies
Revision of EC directives related to medical research
Implementation of equal opportunities for all researchersA doubling of public funding of medical research in Europe within the next ten years – to a minimum of 0.25% of gross domestic product (GDP)
Notes for editor
With its emphasis on a multidisciplinary and pan-European approach, the Foundation provides the leadership necessary to open new frontiers in European science.
Its activities include providing science policy advice (Science Strategy); stimulating co-operation between researchers and organisations to explore new directions (Science Synergy); and the administration of externally funded programmes (Science Management). These take place in the following areas: Physical and engineering sciences; Medical sciences; Life, earth and environmental sciences; Humanities; Social sciences; Polar; Marine; Space; Radio astronomy frequencies; Nuclear physics.
Headquartered in Strasbourg with offices in Brussels and Ostend the ESF’s membership comprises 77 national funding agencies, research performing agencies and academies from 30 European nations.
The Foundation’s independence allows the ESF to objectively represent the priorities of all these members.What is EMRC?
Press contact:Sofia Valleley
Thomas Lau | alfa
Classroom in Stuttgart with Li-Fi of Fraunhofer HHI opened
03.11.2017 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI
Starting school boosts development
11.05.2017 | Max-Planck-Institut für Bildungsforschung
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy